Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial.

Autor: Elias EG, Zapas JL, McCarron EC, Beam SL, Hasskamp JH, Culpepper WJ

Publikováno v: Cancer Biotherapy & Radiopharmaceuticals; Jun2008, Vol. 23 Issue 3, p285-291, 7p

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Autor: Ganz PA; University of California, Los Angeles, Los Angeles, CA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA., Bandos H; NRG Oncology SDMC, The University of Pittsburgh, Pittsburgh, PA., Španić T; Europa Donna-The European Breast Cancer Coalition, Milan, Italy.; Europa Donna Slovenia, Ljubljana, Slovenia., Friedman S; Facing Our Risk of Cancer Empowered, Tampa, FL., Müller V; Depatment of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kuemmel S; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.; Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany., Delaloge S; Gustave Roussy, Villejuif, France., Brain E; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Toi M; Kyoto University Hospital, Kyoto, Japan.; Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan., Yamauchi H; St Luke's International Hospital, Tokyo, Japan., de Dueñas EM; Consorcio Hospitalario Provincial de Castellón, Castellón, Spain.; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Armstrong A; Department of Medical Oncology, Division of Cancer Sciences, The University of Manchester, The Christie Hospital, Manchester, United Kingdom., Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Song CG; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China., Zheng H; West China Hospital, Sichuan University, Chengdu, China., Sarosiek T; Luxmed Onkologia, Warsaw, Poland., Sharma P; University of Kansas Medical Center, Westwood, KS., Geng C; The Fourth Hospital of Hebei Medical University, Shiijazhuang, China., Fu P; Breast Surgery Department, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Rhiem K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Cologne, Germany., Frauchiger-Heuer H; Breast Center Unit, UniversitätsSpital Zürich, Zürich, Switzerland., Wimberger P; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., t'Kint de Roodenbeke D; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Liao N; Guangdong People's Hospital, Guangzhou, China., Goodwin A; Concord Repatriation General Hospital, University of Sydney, Sydney, NSW, Australia., Chakiba-Brugère C; Département d'oncologie médicale, Institut Bergonié, Bordeaux, France., Friedlander M; Prince of Wales Clinical School, University of NSW and Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, NSW, Australia., Lee KS; Center for Breast Cancer, National Cancer Center, Goyang, Republic of Korea., Giacchetti S; Breast Disease Unit (Sénopole), AP-HP, Hôpital Saint-Louis, Paris, France., Takano T; Breast Medical Oncology Department, The Cancer Institute Hospital of JFCR, Tokyo, Japan., Henao-Carrasco F; Hospital Universitario Virgen Macarena GEICAM Spanish Breast Cancer Group, Sevilla, Spain., Virani S; Advocate Aurora Health, Milwaukee, WI., Valdes-Albini F; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Domchek SM; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA., Bane C; Dayton Physicians Network, Dayton, OH., McCarron EC; MedStar Franklin Square Medical Center-Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD., Mita M; Cedars Sinai Medical Center, SOCCI, Los Angeles, CA., Rossi G; Breast International Group (BIG), Brussels, Belgium., Rastogi P; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Magee Women's Hospital, Pittsburgh, PA., Fielding A; Oncology R&D, AstraZeneca, Gaithersburg, MD., Gelber RD; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Boston, MA.; Frontier Science Foundation, Boston, MA., Scheepers ED; Frontier Science (Scotland), Kincraig, United Kingdom., Cameron D; University of Edinburgh, Edinburgh, United Kingdom., Garber J; Dana-Farber/Harvard Cancer Center, Boston, MA., Geyer CE; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA., Tutt ANJ; The Institute of Cancer Research London, London, United Kingdom.; Kings College London, London, United Kingdom.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1288-1300. Date of Electronic Publication: 2024 Feb 01.

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.

Autor: Slingluff CL; Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, USA cls8h@virginia.edu., Lewis KD; University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA., Andtbacka R; Huntsman Cancer Institute Cancer Hospital, Salt Lake City, Utah, USA., Hyngstrom J; Huntsman Cancer Institute Cancer Hospital, Salt Lake City, Utah, USA., Milhem M; The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA., Markovic SN; Mayo Clinic Rochester, Rochester, Minnesota, USA., Bowles T; Intermountain Medical Center, Murray, Utah, USA., Hamid O; Cedars-Sinai Medical Center Angeles Clinic and Research Institute, Santa Monica, California, USA., Hernandez-Aya L; Department of Medicine, Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, USA., Claveau J; CHU de Quebec-Universite Laval, Quebec, Québec, Canada., Jang S; Department of Medical Oncology, Inova Health System, Falls Church, Virginia, USA., Philips P; University of Louisville, Louisville, Kentucky, USA., Holtan SG; University of Minnesota Academic Health Center, Minneapolis, Minnesota, USA., Shaheen MF; University of Arizona Medical Center - University Campus, Tucson, Arizona, USA., Curti B; Earle A Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA., Schmidt W; Bend Memorial Clinic, Bend, Oregon, USA., Butler MO; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Paramo J; Mount Sinai Medical Center, Miami Beach, Florida, USA., Lutzky J; Department of Oncology, Sylvester Comprehensive Cancer Center, Miami, Florida, USA., Padmanabhan A; Baptist Health Lexington, Lexington, Kentucky, USA., Thomas S; MD Anderson Cancer Center Orlando, Orlando, Florida, USA., Milton D; Investigative Clinical Research of Indiana, Indianapolis, Indiana, USA., Pecora A; Department of Oncology, John Theurer Cancer Center, Hackensack, New Jersey, USA., Sato T; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Hsueh E; St. Louis University Hospital, St. Louis, Missouri, USA., Badarinath S; Cancer Specialists of North Florida, Jacksonville, Florida, USA., Keech J; Multicare Institute for Research and Innovation, Tacoma, Washington, USA., Kalmadi S; Ironwood Cancer and Research Centers, Chandler, Arizona, USA., Kumar P; Harry and Jeanette Weinberg Cancer Institute at Franklin Square, Baltimore, Maryland, USA., Weber R; St. Mary's Hospital and Medical Center, San Francisco, California, USA., Levine E; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Berger A; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Bar A; Oregon Health & Science University, Portland, Oregon, USA., Beck JT; Department of Medical Oncology, Highlands Oncology Group, Fayetteville, Arkansas, USA., Travers JB; Premier Health Partners Inc, Dayton, Ohio, USA., Mihalcioiu C; Royal Victoria Hospital, Montreal, Québec, Canada., Gastman B; Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA., Beitsch P; Cancer Solutions, Dallas, Texas, USA., Rapisuwon S; Department of Oncology, Georgetown University Medical Center, Washington, District of Columbia, USA.; Department of Hematology/Oncology, MedStar Washington Hospital Center, Washington, District of Columbia, USA., Glaspy J; University of California Los Angeles, Los Angeles, California, USA., McCarron EC; MedStar Franklin Square Medical Center, Baltimore, Maryland, USA., Gupta V; MedStar Franklin Square Medical Center, Baltimore, Maryland, USA., Behl D; Sutter Institute for Medical Research, Sacramento, California, USA., Blumenstein B; Trial Architecture Consulting, Chevy Chase, Maryland, USA., Peterkin JJ; Polynoma, San Diego, California, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Oct; Vol. 9 (10).

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.

Autor: Bandos H; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Melnikow J; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Rivera DR; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Swain SM; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Sturtz K; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Fehrenbacher L; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Wade JL 3rd; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Brufsky AM; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Julian TB; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Margolese RG; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., McCarron EC; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA., Ganz PA; NRG Oncology and The University of Pittsburgh, Pittsburgh, PA; Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD; NRG Oncology and The Washington Cancer Institute at Washington Hospital Center, Washington, DC and current: Georgetown University, Washington, DC; NRG Oncology and The Colorado Cancer Research Program, Denver, CO; NRG Oncology and Kaiser Permanente, Northern California, Vallejo, CA; NRG Oncology and The Central Illinois CCOP Heartland NCORP, Decatur, IL; NRG Oncology and The University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA; NRG Oncology and The Allegheny Health Network, Pittsburgh, PA; NRG Oncology and The Jewish General Hospital, McGill University, Montréal, QC, Canada; NRG Oncology and The MedStar Franklin Square Medical Center/Harry and Jeanette Weinberg Cancer Institute, Baltimore, MD; NRG Oncology and The University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2018 Feb 01; Vol. 110 (2).

Approaches for economic evaluations of health care technologies.

Autor: Tarride JE; Programs for Assessment of Technology in Health Research Institute, St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada. tarride@mcmaster.ca, Blackhouse G, Bischof M, McCarron EC, Lim M, Ferrusi IL, Xie F, Goeree R

Publikováno v: Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2009 May; Vol. 6 (5), pp. 307-16.